Lin Wang
Lin Wang publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Ubiquitin and proteasome pathways, Cytokine Signaling Pathways and Interactions and Prostate Cancer Treatment and Research.
- World rank
- #742,983 of 7,710,434 ranked researchers
- Rank in China
- #98,945 of 978,568
- Works
- 556
- Citations
- 12k
- Citations per work
- 22.2
What does Lin Wang research?
Lin Wang's work is mostly in Biochemistry, Genetics and Molecular Biology (29%), Medicine (13%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else29553.0%
- Life Sciences18733.6%
- Health Sciences7513.4%
- Medicine7513.4%
- 1Molecular Biology20% of their works
- 2Oncology8% of their works
- 3Pulmonary and Respiratory Medicine5% of their works
- 4Cancer Research5% of their works
- 5Immunology5% of their works
- 6Cell Biology4% of their works
Research topics
- Ubiquitin and proteasome pathways
- Cytokine Signaling Pathways and Interactions
- Prostate Cancer Treatment and Research
- Cancer-related Molecular Pathways
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Endoplasmic Reticulum Stress and Disease
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe Lin Wang's research?
The keywords of their largest research topics: Cancer Therapy, Cancer, Tumor Microenvironment, Apoptosis, IL-6, Proteasome, STAT3 and Ubiquitin.
- Warburg Effect
- Stress
- Long Noncoding RNAs
- Fc Receptors
- p53
- Prostate Cancer
- Ubiquitin
- Proteasome
- Apoptosis
- Cancer
- Cancer Therapy
- Tumor Microenvironment
- IL-6
- STAT3
- Androgen Receptor
- Cell Cycle
- Endoplasmic Reticulum
- HIF-1
- RNA Regulation
- Therapeutic Antibodies
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cancer Therapy432 topics
- Cancer412 topics
- Tumor Microenvironment412 topics
- Apoptosis302 topics
- IL-6271 topic
- Proteasome271 topic
- STAT3271 topic
- Ubiquitin271 topic
- Androgen Receptor191 topic
- Prostate Cancer191 topic
- Cell Cycle161 topic
- p53161 topic
- Endoplasmic Reticulum141 topic
- Fc Receptors141 topic
- HIF-1141 topic
- Long Noncoding RNAs141 topic
- RNA Regulation141 topic
- Stress141 topic
- Therapeutic Antibodies141 topic
- Warburg Effect141 topic
Where does Lin Wang work?
Lin Wang's main affiliation in the publication record is Shandong University, China.
How many publications and citations does Lin Wang have?
OpenAlex counts 556 works and 12,370 citations for Lin Wang, an h-index of 54, ranking #742,983 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Lin Wang
- lin-wang-huazhong-university-of-science-and-technology-china
- lin-wang-chinese-academy-of-sciences
- lin-wang-nanjing-tech-university
- lin-wang-fudan-university
- lin-wang-chinese-academy-of-medical-sciences-and-peking-union-medical-college
- lin-wang-second-affiliated-hospital-of-zhejiang-university
- lin-wang-university-of-florida
- lin-wang-shanghai-jiao-tong-university
- lin-wang-huazhong-university-of-science-and-technology
- lin-wang-chinese-academy-of-sciences-china
- lin-wang-huazhong-university-of-science-and-technology-china-2
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lin Wang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.